Each one in plain English, with the numbers worked through for a shareholder.
30 Apr 2025quarterly activities report● Neutral
March quarter report recapping completion of the Araxá acquisition on 27 February, the maiden resource (41.2Mt at 0.68% Nb2O5; 40.64Mt at 4.13% TREO) and Xinhai's A$8m investment and EPC+F role. Largely repeats earlier announcements.
Company argues Araxá's 40.64Mt at 4.13% TREO resource matters given China's rare earths export restrictions, comparing it with Lynas's Mt Weld (106Mt at 4.1%). Also joins the MAGBRAS magnet initiative; drilling is due in the coming weeks. Largely promotional, with no new results.
Presentation for the Tribeca commodities conference in Singapore, repeating the Araxá story and the 1 April maiden resource. It contains no new results or figures.
Maiden JORC resource for Araxá: 41.2Mt at 0.68% Nb2O5 (280kt contained) and 40.64Mt at 4.13% TREO (1.7Mt contained). Most is Inferred (about 31.9Mt); measured and indicated total 9.27Mt. Delivers the resource targeted since the February acquisition.
Half-year to 31 December 2024: loss of $3.54m (prior year $4.97m) on revenue of $101,943, with exploration spend of $2.23m written off. The report recaps the Araxá acquisition, completed 27 February 2025, and the $20m raising.
Bench-scale metallurgical testwork has started on three samples of over 60kg each from historical Araxá drilling, with EMBRAPII and SENAI, focused on flotation recovery of niobium and rare earths. A drill campaign is also due to start this month.
Top 20 holder list for the new placement options as at 24 February 2025. Xinhai holds 87.5m (10.16%) and Itafos 86.1m (10.00%) of the options. Administrative register data with no new business information.
Distribution schedule for the February 2025 options: 861,111,025 options held by 132 holders. Administrative register data with no new business information.
Investor presentation marking completion of the 100% Araxá niobium-REE acquisition, restating known facts: adjacent to CBMM, more than 500 historical intercepts, grades up to 8% Nb2O5 and 33% TREO. No new results or figures beyond earlier announcements.
27 Feb 2025asset acquisition disposition▲ GoodMajor
St George completed the 100% acquisition of the Araxá niobium-REE project, paying US$6.97m cash and issuing Itafos 266.8m shares (10%), 86.1m $0.04 options and 11.1m performance rights. The $20m raising is complete; a 5,000m drill program is planned from March 2025.
At St George's request, trading was suspended pending an announcement on completing the Araxá acquisition. It was to last until an announcement or normal trading on 27 February 2025.
Carlos Alberto de Araújo, who worked at CBMM from 2008 to 2023 on its niobium processing plant, joins the Araxá delivery team to advise on plant design. The general meeting on the acquisition was held the same day.
Shareholders approved all resolutions for the Araxá acquisition at the general meeting, clearing the $20m raising and related issues. Financial completion is scheduled for 24 February 2025, resolving the main condition outstanding since August 2024.
Cleansing prospectus offering 1,000 shares at $0.02 (to raise $20) and 861,111,025 options exercisable at $0.04 for two years. It is a administrative filing tied to the placement and acquisition securities; no new business information.
Binding MoU with mining engineering firm Xinhai, which has committed A$8m of the A$20m raising. Parties will negotiate a partnership within nine months, giving Xinhai first and last right of refusal on an EPCM+O contract and marketing rights to 80% of niobium offtake into China.
Ricardo Nardi, who worked at CBMM's Araxá operations from 1982 to 2021, joins as consultant for mineral processing at Araxá. He will advise on metallurgical studies, flow sheet design and feasibility work.
December quarter report: Araxá acquisition still expected to complete in Q1 2025, with new MoUs recapped. Destiny drilling showed the C1 and C3 gravity targets are mafic/ultramafic intrusions, not carbonatites, with copper up to 0.17%, resolving the earlier niobium-REE carbonatite hypothesis.
Non-binding MoU with steelmaker Liaoning Fangda Group on Araxá, covering possible offtake of at least 20% of niobium products, funding support and technical help. Parties aim to negotiate a binding deal within nine months; no financial obligation on St George.
St George signed a technical collaboration agreement with Brazilian agencies EMBRAPII and SENAI to develop a processing method for niobium and rare earths from Araxá. Costs split 50% EMBRAPII, 10% SENAI, 40% St George; St George gets 10 years' exclusive commercial rights to the resulting IP, with no royalty.
Firm commitments for a $20m placement of 1,000,000,000 shares at $0.02, with one free $0.04 option per two shares, to fund Araxá. It replaces the August 2024 raising and needs shareholder approval. Closing deadline extended to 15 March 2025.
What it means for a shareholder
1.00bn new shares at $0.020 to raise about $20.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
ASX notice that trading in St George shares, suspended since 30 October 2024, resumes at the start of trading following the Araxá funding announcement.
Ninth extension of the voluntary suspension to finalise Araxá funding, now running to 8 January 2025 at the latest, or earlier on an announcement. No new information.
Eighth extension of the voluntary suspension to finalise Araxá funding, now running to 6 January 2025 at the latest, or earlier on an announcement. No new information.
Seventh extension of the voluntary suspension to finalise Araxá funding, now running to 2 January 2025 at the latest, or earlier on an announcement. No new information.
Sixth extension of the voluntary suspension to finalise Araxá funding, now running to 20 December 2024 at the latest, or earlier on an announcement. No new information.
St George signed two five-year MoUs with SENAI, one on rare earth magnet production at its Lab Fab facility and one on sustainable niobium and rare earths processing. The Araxá acquisition is still expected to close in Q1 2025.
Fifth extension of the voluntary suspension to finalise Araxá funding, now running to 13 December 2024 at the latest, or earlier on an announcement. No new information.
Cleansing prospectus for up to 1,000 shares at $0.02 to raise $20, lodged so shares from the December placement can be freely traded. Administrative filing with no new business information.
3 Dec 2024capital raising announcement● NeutralMajor
St George secured firm commitments for a $3m placement of 150m shares at $0.02, with one free option per two shares (exercise $0.04, two years). It funds working capital and existing projects; a separate raising for Araxá is still planned.
What it means for a shareholder
150m new shares at $0.020 to raise about $3.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.